The SELECT cardiovascular outcomes trial showed that semaglutide 2.4 mg significantly reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in patients with established cardiovascular disease and overweight or obesity, even without type 2 diabetes
Protein: the most critical supplement for tirzepatide users If you only address one nutritional gap while on tirzepatide, make it protein
The product is available in both 1mL and 3mL vial sizes, giving healthcare providers flexibility in prescribing based on individual patient protocols and tirzepatide dose requirements
Cardiovasc Res 118(17):32723287
HUBERMAN: And this is actually going to be a pretty quick discussion because really the main one in this category, besides thymus and beta-4, remember thymus and beta-4 we talked about earlier, this is a peptide that's naturally released from the thymus and the thymus is a structure that depletes over time as children age